Semler Scientific, Inc. (NASDAQ:SMLR) Short Interest Up 20.1% in March

Semler Scientific, Inc. (NASDAQ:SMLR) saw a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 1,790,000 shares, a growth of 20.1% from the March 15th total of 1,490,000 shares. Based on an average daily volume of 407,200 shares, the short-interest ratio is currently 4.4 days. Currently, 23.0% of the shares of the stock are short sold.

Analyst Upgrades and Downgrades

Separately, Lake Street Capital increased their price target on shares of Semler Scientific from $40.00 to $71.00 and gave the stock a “buy” rating in a research report on Friday, January 24th.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of SMLR. State Street Corp boosted its position in Semler Scientific by 0.6% during the 3rd quarter. State Street Corp now owns 118,223 shares of the company’s stock worth $2,784,000 after buying an additional 725 shares during the period. Jane Street Group LLC increased its holdings in Semler Scientific by 72.3% in the third quarter. Jane Street Group LLC now owns 16,982 shares of the company’s stock valued at $400,000 after purchasing an additional 7,126 shares during the period. Geode Capital Management LLC raised its position in Semler Scientific by 10.5% during the 3rd quarter. Geode Capital Management LLC now owns 135,959 shares of the company’s stock worth $3,202,000 after purchasing an additional 12,964 shares during the last quarter. Sanctuary Advisors LLC bought a new position in shares of Semler Scientific during the third quarter worth about $104,000. Finally, Principal Financial Group Inc. acquired a new position in shares of Semler Scientific in the third quarter worth approximately $361,000. 49.37% of the stock is currently owned by institutional investors.

Semler Scientific Stock Performance

Semler Scientific stock opened at $29.83 on Tuesday. Semler Scientific has a 52 week low of $20.88 and a 52 week high of $81.56. The stock has a market capitalization of $286.28 million, a P/E ratio of 6.08 and a beta of 1.29. The stock has a fifty day moving average of $38.32 and a 200-day moving average of $45.99.

Semler Scientific (NASDAQ:SMLR) last announced its quarterly earnings results on Tuesday, February 18th. The company reported $3.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.20 by $3.21. The company had revenue of $12.41 million for the quarter. Semler Scientific had a net margin of 72.65% and a return on equity of 50.77%.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.